With reversed-phase high-performance liquid chromatography we effected rapid and efficient separation of metabolites present in hemodialysate fluid from uremic patients on the artificial kidney. With an aqueous sodium acetate/methanol gradient as mobile phase, more than 50 ultraviolet-absorbing constituents were resolved in a 70-mm chromatogram of a 100-tl sample of dialysate. Many of the metabolites could be detected in concentrations below 0.1 mg/liter. From results of ultraviolet spectrophotometric analysis and the gas-and liquidchromatographic properties of standards, half the observed chromatographic peaks have been characterized or identified. The method has been shown to be more than 10-fold faster than comparable separations by ion-exchange techniques. 
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Materials and Methods

Sample and Standard Preparation
Hemodialysate samples were obtained from a single dialysis of a 58-year-old male patient who had been diagnosed to be in chronic renal failure. He was restricted to a low-protein diet and regularly received aluminum hydroxide and warfarin as medication, in addition to a daily dietary vitamin supplement. Two- Associates).
Gas Chromatography
Standards and eluted sample collected from the liquid chromatograph were evaporated under reduced pressure (133 Pa; 1 mmHg) at 25 #{176}C with a rotary evaporator, then quantitatively transferred with 1-2 ml of methanol to a low-volume silylation vial. After subsequent removal of the methanol under a stream of dry nitrogen, the vial was equipped with an air-tight "Mininert" valve (Supelco, Bellefonte, Pa. 16823). Trimethylsilyl derivatives of the components were prepared by dissolving the resulting residue in 25 il of pyridine and reacting the mixture with 25 tl of N,Obis(trimethylsilyl)trifluoroacetamide (Pierce Chemical Co., Rockford, Ill. 61105) for 30 mm at ambient temperature.
The derivatized components were separated on a Model 900 gas chromatograph (Perkin-Elmer, Norwalk, Conn. 06854) that was equipped with a 3.6 mm X 2 mm (i.d.) 3.3% SE-30 on 100-120 mesh Gas Chrom Q in a glass column (Applied Science Lab. Inc., State College, Pa. 16801). Helium was used as the carriergas,at a flow rate of 37 mi/mm and at a column inlet pressure of 415 kPa (60 psig). The instrument was equipped with a glass-lined injection port operated at 265 #{176}C. Eluted components were monitored by means of a flame ionization detector. The column was operated isothermally at 80 #{176}C during the initial 8 mm of a run and was then programmed to increase to 260 #{176}C at 5 #{176}C/min, the final temperature being maintained for 30 mm.
Ultraviolet Spectroscopy
Peaks were identified by ultraviolet spectral analysis of collected fractions that contained the eluted components. To eliminate the spectral uncertainty associated with attempting to match the absorbance of a reference solvent to that of the solvent collected during 
#{176}C on a rotary evaporator; they were then re-injected into an isocratic nonabsorbing mobile phase. By using doubly distilled water to elute components with initial gradient liquid-chromatographic retention times of 30 mm or less (and methanol for more strongly retained compounds), we easily separated sample components from the sodium acetate present in the original eluent. The ultraviolet absorption spectra of collected compounds were recorded with a Model DB-GT Grating Spectrophotometer (Beckman Instruments, Fullerton, Calif. 92634), with use of 1 ml, 1-cm pathlength quartz cells. Spectra of low concentration components with absorbance values below 0.1 were recorded by increasing the recorder sensitivity 10-fold (Beckman 10-inch recorder).
Results
The
Our initial approach was to identify tentatively the major metabolites through a cursory examination of the elution properties of pure compounds. The chromatographic characteristics of these metabolites were then more closely examined as a function of the composition of the mobile phase, in order to elucidate their structural features. Through a similar examination of the elution characteristics of chromatographic peaks of actual dialysate samples, corroborative support was given to the tentative identification of the metabolites, and preliminary data were provided concerning the chemical nature of yet-unidentified components. Using the recent literature on blood and urine analysis as a guide, we examined the elution behavior of more than 50 biochemicals. A typical chromatogram for a standard mixture containing 23 pure compounds is illustrated in Figure 2 . Prospective components were eluted both individually and in conjunction with dialysate samples. Table 1 lists 23 compounds that have been identified in used hemodialysate solutions, not all of which are products of metabolic pathways. For example, benzyl alcohol, theobromine, and theophylline The elution characteristics of a select group of metabolites were then studied as a function of eluent pH (3.5-7.5). As anticipated, the chromatographic retention times depended greatly on chemical structure. The distribution of sample components between the polar aqueous mobile phase and the nonpolar octadecylsilane stationary phase was a function of both the acidity and the hydrophobic nature of the compound. Only the uncharged protonated form of an acid or the free base is expected to have much affinity for the nonpolar phase. The results of this study are presented in Figure  3 . As the weak acids, such as indoleacetic acid or ferulic acid (curves 1 and 2 in Figure 3 , respectively), became progressively more ionized with increasing pH of the mobile phase, the capacity factors, k', for these compounds decreased markedly. Weak bases such as creatinine (curve 16) or nicotinamide (curve 11) on the other hand, which are ionic at low pH values, displayed an increased retention time with increases in eluent pH. Non-ionized compounds and molecules such as tyrosine, which possess both weakly acidic and basic functional groups, remained relatively unaffected by variations in pH. Although both the protonated and ionized form of acidic substances exist in solution at intermediate pH values, the rapidityof the interconversion between the two forms relative to the rate of the chromatographic process results in the observation of only a single chromatographic peak. The retention time for this single peak reflects the equilibrium concentrations of the two forms in which the compound may exist at the pH under investigation. Although the ionizability of an acid or base is a function of its dissociation constant, it is not possible in the present study, in which an aqueous/ methanol gradient was used, to present a direct correlation of the inflection points observed in Figure 3 with the PKa values reported in the literature for aqueous solutions of these compounds. The gradient used in our investigation reduced the k' values of the more highly retained components to more reasonable values. Optimum resolution and reproducibility for the standard compounds was obtained at an eluent pH of 4.5. At this pH, as shown by the nearly horizontal slope of the curves in Figure 3 , the sample components are relatively unaffected by small variations in pH of the mobile phase, and the separation factors are optimum. Also, the buffering capacity of aqueous sodium acetate is very high at this pH.
A number of the components were also studied with respect to their sensitivity toward ultraviolet detection. As shown in Figure 4 , the responses of 12 metabolites were found to be linear to >1 ig of sample, which is more than the amount per sample expected for most of the constituents in spent hemodialysate. The detection limits for these metabolites were estimated as that amount of each compound that gave a signal-to-noise ratio of two. The limiting factor in detection was the "noise" derived from variations in the solvent refractive index as a result of oscillations in the flow rate caused by the pump. For many of the components, the detection limits were below the 15 ng level. These detection limits are summarized in Table 1 . Figure 5 shows a chromatogram for used hemodialysate fluid that had been concentrated 10-fold in order to facilitate the detection and indentification of peak components. Although we saw similarities among chromatograms of dialysate samples collected from different patients, it is difficult to present a chromatogram that one might consider "typical" of the uremic state. The composition of used hemodialysate fluid is related to the patient and the medication he or she is receiving. A recent article On the nursing care of dialysis patients listed 42 causes of acute and chronic renal failure (11), ranging from simple pre-and post-renal blockage to total deterioration of the nephrons. The metabolites listed with Figure 5 were tentatively identified on the basis of the retention characteristics of pure compounds. The compounds indicated by footnote a in Table 1 have been further confirmed by gas-chromatographic retention times or through ultraviolet spectrophotometric analysis. A small concentration of benzyl alcohol was found in the dialysate sample, presumably originating from the presence of this compound as a preservative in the heparin preparations that are administered intermittently and intravenously to a patient as an anticoagulant during dialysis.
Discussion
In the past, the search for uremic toxins has been very selective. Research has been aimed at studying the concentrations of single metabolic constituents in blood. Because of the interrelated nature of the metabolites associated with the uremic syndrome, and the lack of chemical tests for identification and quantification, much of the information gathered to date is at best controversial. High concentrations of certain metabolites have been shown to be enzymatic inhibitors and it has been suggested that others cause metabolic cycles to take secondary pathways (1, 3) . Through the use of reversed-phase liquid chromatography, we have been able to obtain a total profile of the ultraviolet absorbing constituents in hemodialysate solution. Dialysate fluid is readily available, and, except for filtration, requires no sample preparation before analysis. Our procedure permits quantitative measurement of metabolites removed during hemodialysis. Preliminary data indicate a correlation between metabolite concentrations in dialysate and in blood. The method has been shown to be more than an order of magnitude faster than comparable separations by ion-exchange techniques that have been applied to urine analysis (8, 9) . Utilization of this chromatographic screening approach will facilitate clinical studies of the interrelative metabolic causes of the uremic syndrome.
Continued work involving liquid chromatography, gas chromatography, and mass spectrometry is presently underway in these laboratories, to further identify and quantify uremic toxins present in dialysate. Results of these studies should contribute to a better understanding of the importance of specific metabolites in the uremic syndrome. We anticipate that these investigations will ultimately
lead to the refinement of dialysis membranes and procedures, and to the development of screening approach to the definition of uremic toxins. Kidney mt., new biochemical/pharmaceutical modalities for treatSuppl. 2,845(1975 Biomed.
Mass Spectrom. 2, 145 (1975) .
